<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941205-2-00029</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=11 g=1 f=1 --> A novel method has been developed to quickly evaluate and  <!-- PJG 0012 frnewline --> screen potential anti-cancer and anti-viral drugs in vivo. The  <!-- PJG 0012 frnewline --> desire for effective treatments for tumors and viral infections  <!-- PJG 0012 frnewline --> has created a need in the research and medical communities for a  <!-- PJG 0012 frnewline --> quick, reliable way to test chemotherapeutic agents. Although  <!-- PJG 0012 frnewline --> several teams of investigators have attempted in recent years to  <!-- PJG 0012 frnewline --> develop in vivo methods for screening such drugs, these methods  <!-- PJG 0012 frnewline --> have had limited value because they usually permit only the agent  <!-- PJG 0012 frnewline --> to be tested against one type of tumor cell or cell line per  <!-- PJG 0012 frnewline --> experiment and/or have been labor intensive and expensive. This  <!-- PJG 0012 frnewline --> new method for screening chemotherapeutic agents involves  <!-- PJG 0012 frnewline --> encapsulating the target (i.e., tumor) cells in a biocompatible,  <!-- PJG 0012 frnewline --> semipermeable membrane_which is made of unique hollow fibers  <!-- PJG 0012 frnewline --> or dialysis tubing_and transplanting the encapsulated cells  <!-- PJG 0012 frnewline --> into a laboratory animal. Each laboratory animal can receive an  <!-- PJG 0012 frnewline --> implant at a single site or multiple sites, making it possible to  <!-- PJG 0012 frnewline --> test a chemotherapeutic agent against several types of tumor  <!-- PJG 0012 frnewline --> cells simultaneously. The membrane, which does not generate an  <!-- PJG 0012 frnewline --> autoimmune response or release any toxic chemicals, allows for  <!-- PJG 0012 frnewline --> the target cells to be reharvested after the treatment.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=84 g=1 f=1 --> Sensitive Method For Locating Chromosomal Breakpoints  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=16 g=1 f=1 --> Magrath, I.T., Shiramizu, B. (NCI)  <!-- PJG 0012 frnewline --> Filed 2 Dec 93  <!-- PJG 0012 frnewline --> Serial No. 08/160,547 (CON of 07/698,233, CON of 07/441,516) <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> A new technique for localizing chromosomal breakpoints  <!-- PJG 0012 frnewline --> offers a significant advancement in detecting genetic  <!-- PJG 0012 frnewline --> translocations such as those found in Burkitt's lymphoma. Present  <!-- PJG 0012 frnewline --> techniques for detecting chromosomal breakpoints require large  <!-- PJG 0012 frnewline --> amounts of tumor sample, are often insensitive, or are cumbersome  <!-- PJG 0012 frnewline --> and time consuming. This new technique utilizes sequence-specific  <!-- PJG 0012 frnewline --> primers for rapid, efficient PCR amplification of a fragment  <!-- PJG 0012 frnewline --> containing a breakpoint. This technique is so sensitive it can be  <!-- PJG 0012 frnewline --> used to sub-divide Burkitt's lymphomas into subtypes based on the  <!-- PJG 0012 frnewline --> location of chromosomal breakpoints.  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=85 g=1 f=1 --> Method For Estimating mRNA Content By Filter Hybridization To A  <!-- PJG 0012 frnewline --> Polythymidylate Probe  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=16 g=1 f=1 --> Hollander, M.C., Fornace, A.J. (NCI)  <!-- PJG 0012 frnewline --> Filed 21 Feb 94  <!-- PJG 0012 frnewline --> Serial No. 08/183,911 (CON of 07/908,814, CON of 07/501,774)  <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=11 g=1 f=1 --> A method for the quantitation of relative mRNA samples which  <!-- PJG 0012 frnewline --> entails hybridization of a polythymidylate (polyT) probe with RNA  <!-- PJG 0012 frnewline --> bound to an insoluble substrate. This method is especially  <!-- PJG 0012 frnewline --> applicable for normalizing numerous RNA samples which are to be  <!-- PJG 0012 frnewline --> analyzed by dot blot hybridization. The relative hybridization of  <!-- PJG 0012 frnewline --> polyT probe to RNA is proportional to the polyA RNA content of  <!-- PJG 0012 frnewline --> the RNA samples. Since the hybridization of polyT probe to RNA  <!-- PJG 0012 frnewline --> does not appear to be dependent on any cell treatment or growth  <!-- PJG 0012 frnewline --> condition and experimental variation is minimized, this method is  <!-- PJG 0012 frnewline --> a better method for standardizing the amount of mRNA in RNA  <!-- PJG 0012 frnewline --> samples than is relative hybridization to cDNA probes such as  <!-- PJG 0012 frnewline --> actin or  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=6 f=1 --> b <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=5 f=2 --> 2 <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> -microglobulin, the transcript levels of which may  <!-- PJG 0012 frnewline --> vary according to cell treatment.  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            